tiprankstipranks
Trending News
More News >
Koninklijke Philips (GB:0A2M)
LSE:0A2M
Advertisement

Koninklijke Philips (0A2M) Price & Analysis

Compare
1 Followers

0A2M Stock Chart & Stats

$27.55
-$0.05(-0.21%)
At close: 4:00 PM EST
$27.55
-$0.05(-0.21%)

Koninklijke Philips News

0A2M FAQ

What was Koninklijke Philips’s price range in the past 12 months?
Koninklijke Philips lowest share price was $21.60 and its highest was $32.54 in the past 12 months.
    What is Koninklijke Philips’s market cap?
    Koninklijke Philips’s market cap is $26.08B.
      When is Koninklijke Philips’s upcoming earnings report date?
      Koninklijke Philips’s upcoming earnings report date is Nov 04, 2025 which is in 20 days.
        How were Koninklijke Philips’s earnings last quarter?
        Koninklijke Philips released its earnings results on Jul 29, 2025. The company reported $0.415 earnings per share for the quarter, beating the consensus estimate of $0.316 by $0.099.
          Is Koninklijke Philips overvalued?
          According to Wall Street analysts Koninklijke Philips’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Koninklijke Philips pay dividends?
            Koninklijke Philips does not currently pay dividends.
            What is Koninklijke Philips’s EPS estimate?
            Koninklijke Philips’s EPS estimate is 0.37.
              How many shares outstanding does Koninklijke Philips have?
              Koninklijke Philips has 962,920,100 shares outstanding.
                What happened to Koninklijke Philips’s price movement after its last earnings report?
                Koninklijke Philips reported an EPS of $0.415 in its last earnings report, beating expectations of $0.316. Following the earnings report the stock price went up 8.197%.
                  Which hedge fund is a major shareholder of Koninklijke Philips?
                  Currently, no hedge funds are holding shares in GB:0A2M

                  Company Description

                  Koninklijke Philips

                  Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

                  Koninklijke Philips (0A2M) Earnings & Revenues

                  0A2M Company Deck

                  0A2M Earnings Call

                  Q2 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Positive
                  The earnings call reflected a generally positive outlook, with strong order intake growth and improvements in adjusted EBITA margin driven by innovation and productivity measures. However, challenges such as the decline in Connected Care sales, subdued performance in China, and the impact of tariffs were noted. Despite these challenges, the Company has increased its adjusted EBITA margin and free cash flow outlook, indicating confidence in its ongoing strategies.View all GB:0A2M earnings summaries
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Abbott Laboratories
                  Boston Scientific
                  Dexcom
                  Strata Skin Sciences
                  Stryker

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis